Article
Oncology
Philipp Krausewitz, Niklas Kluemper, Ayk-Peter Richter, Thomas Buettner, Glen Kristiansen, Manuel Ritter, Joerg Ellinger
Summary: This study found that SEPT9 and SHOX2 were highly methylated in PCa tissue and could discriminate disease status, tumor stage, and grade. In ccfDNA, the methylation of these two biomarkers allowed discrimination of localized and metastatic disease and increased shortly after prostate biopsy only in PCa patients. Therefore, mSEPT9 and mSHOX2 are promising non-invasive measures for PCa evaluation.
Review
Oncology
Natalia Birknerova, Veronika Mancikova, Evan David Paul, Jan Matyasovsky, Pavol Cekan, Vladimir Palicka, Helena Parova
Summary: Liquid biopsy is a promising alternative to tissue biopsies, offering real-time detection and monitoring of tumor properties. It has significant implications for the diagnosis and prognosis of advanced stage head and neck cancer patients.
Article
Oncology
Juan Ruiz-Banobre, Aitor Rodriguez-Casanova, Nicolas Costa-Fraga, Aida Bao-Caamano, Ana Alvarez-Castro, Martin Carreras-Presas, Elena Brozos-Vazquez, Yolanda Vidal-Insua, Francisca Vazquez-Rivera, Sonia Candamio-Folgar, Manuel Mosquera-Presedo, Ramon M. Lago-Leston, Laura Muinelo-Romay, Jose Angel Vazquez-Bueno, Rebeca Sanz-Pamplona, Victor Moreno, Ajay Goel, Lourdes Castillo, Ana C. Martin, Rocio Arroyo, Manel Esteller, Ana B. Crujeiras, Rafael Lopez-Lopez, Angel Diaz-Lagares
Summary: Hypermethylation of the LINC00473 promoter is a promising biomarker for the noninvasive early detection of colorectal cancer and related precancerous lesions.
CLINICAL EPIGENETICS
(2022)
Article
Multidisciplinary Sciences
Xiao Zhou, Zhen Cheng, Mingyu Dong, Qi Liu, Weiyang Yang, Min Liu, Junzhang Tian, Weibin Cheng
Summary: A diagnostic model using tumor fractions deciphered from circulating cfDNA methylation signatures has been developed for early-stage cancer detection, exhibiting an 86% sensitivity. The approach demonstrates the potential of tumor fractions in cancer early diagnosis, which can be further utilized for cancer screening and tumor progression monitoring.
NATURE COMMUNICATIONS
(2022)
Article
Oncology
Qingxiao Fang, Ziming Yuan, Hanqing Hu, Weiyuan Zhang, Guiyu Wang, Xishan Wang
Summary: Through genome-wide analysis and validation, we identified four CpG sites (cg04486886, cg06712559, cg13539460, and cg27541454) as DNA methylation markers in colorectal cancer tissues. The diagnostic prediction model based on these markers can effectively distinguish colorectal cancer from polyp patients, and the md-score can robustly detect colorectal cancer. The cg27541454 may be a promising candidate noninvasive biomarker for early diagnosis of colorectal cancer.
CLINICAL EPIGENETICS
(2023)
Article
Oncology
Xin Yang, Xiaofeng Wen, Qin Guo, Yunfeng Zhang, Zhenxing Liang, Qian Wu, Zhihao Li, Weimei Ruan, Zhujia Ye, Hong Wang, Zhiwei Chen, Jian-Bing Fan, Ping Lan, Huashan Liu, Xianrui Wu
Summary: This study established a prognostic prediction model based on noninvasive circulating tumor DNA methylation markers for colorectal cancer patients. The model was able to classify patients into high recurrence risk and low recurrence risk groups. The model demonstrated robust predictive potential.
CLINICAL EPIGENETICS
(2022)
Article
Cell Biology
Sara Bonlokke, Magnus Stougaard, Boe Sandahl Sorensen, Berit Bargum Booth, Estrid Hogdall, Gitte-Bettina Nyvang, Jacob Christian Lindegaard, Jan Blaakaer, Jesper Bertelsen, Katrine Fuglsang, Mikael Lenz Strube, Suzan Lenz, Torben Steiniche
Summary: Circulating cell-free HPV DNA (ccfHPV DNA) can serve as a marker for cervical cancer. This study used digital droplet PCR (ddPCR) to detect and quantify ccfHPV DNA in plasma from patients with HPV16- or HPV18-associated cervical cancer. The results showed that ccfHPV DNA may not be useful for early detection of cervical cancer, but it can be a promising tool for establishing tumor burden and monitoring the disease in advanced stage cervical cancer patients.
Review
Biochemistry & Molecular Biology
Anelis Maria Marin, Heloisa Bruna Soligo Sanchuki, Guilherme Naccache Namur, Miyuki Uno, Dalila Luciola Zanette, Mateus Nobrega Aoki
Summary: The lack of reliable early diagnostic tools is a major challenge in managing pancreatic cancer, which is often diagnosed at an advanced stage. The emergence of liquid biopsy as a less invasive approach focusing on plasmatic biomarkers such as DNA and RNA has addressed this issue. Circulating tumor cells (CTCs) and cell-free nucleic acids (cfNAs) like DNA, mRNA, and non-coding RNA (miRNA and lncRNA) in the blood of cancer patients have been investigated as potential biomarkers. This article focuses on circulating cfNAs as plasmatic biomarkers for pancreatic cancer and analyzes their advantages compared to traditional biopsy methods.
Article
Oncology
Nana Jin, Chau-Ming Kan, Xiao Meng Pei, Wing Lam Cheung, Simon Siu Man Ng, Heong Ting Wong, Hennie Yuk-Lin Cheng, Wing Wa Leung, Yee Ni Wong, Hin Fung Tsang, Amanda Kit Ching Chan, Yin Kwan Evelyn Wong, William Chi Shing Cho, John Kwok Cheung Chan, William Chi Shing Tai, Ting-Fung Chan, Sze Chuen Cesar Wong, Aldrin Kay-Yuen Yim, Allen Chi-Shing Yu
Summary: This study found that the transcriptomic component from intestinal secretory cells was significantly decreased in cfRNA obtained from plasma of colorectal cancer patients. The expression of three genes remained consistent across cfRNA and tissue samples. The identified biomarkers in this study need further validation in a larger sample size to determine their potential use in early diagnosis of colorectal cancer.
FRONTIERS IN ONCOLOGY
(2023)
Article
Oncology
Ryo Ohta, Takeshi Yamada, Hiromichi Sonoda, Akihisa Matsuda, Seiichi Shinji, Goro Takahashi, Takuma Iwai, Kohki Takeda, Koji Ueda, Sho Kuriyama, Toshimitsu Miyasaka, Yasuyuki Yokoyama, Keisuke Hara, Hiroshi Yoshida
Summary: This study evaluated the quantity of trans-renal ctDNA and plasma ctDNA, concluding that they have equal potential and combination analysis significantly improves the sensitivity for KRAS mutation detection. In early cancer stages, trans-renal ctDNA had higher sensitivity for detecting KRAS mutations, while it was less useful in advanced stages. Notably, KRAS mutations were detected using ctDNA or trans-renal ctDNA in some patients who had no mutations in their tissue samples.
Review
Oncology
Suzanna J. Schraa, Karlijn L. van Rooijen, Miriam Koopman, Geraldine R. Vink, Remond J. A. Fijneman
Summary: This review provides an overview of the current knowledge regarding the association between preoperative ctDNA detection and the risk of recurrence in colorectal cancer patients. However, the current literature is insufficient to determine this association. More dedicated studies focusing on the prognostic value of preoperative ctDNA are needed, as well as standardization in reporting results to improve comparability among studies.
Review
Pathology
Ruyue Xue, Lu Yang, Meijia Yang, Fangfang Xue, Lifeng Li, Manjiao Liu, Yong Ren, Yu Qi, Jie Zhao
Summary: Lung cancer is a leading cause of cancer-related death, and early diagnosis is crucial. Plasma circulating cell-free DNA (cfDNA) can be used non-invasively and cost-effectively to detect lung cancer through high-sensitivity sequencing techniques, as it contains comprehensive genetic and epigenetic information from tissues throughout the body.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
(2023)
Review
Medicine, Research & Experimental
Van K. Morris, John H. Strickler
Summary: Patient-specific biomarkers are crucial for precision medicine, and in the case of colorectal cancer (CRC), analyzing cfDNA can be used for detecting minimal residual disease, monitoring treatment response, identifying drivers of treatment sensitivity and resistance, and guiding therapeutic strategies. As diagnostic technology continues to improve, more innovative applications of cfDNA analysis are expected.
ANNUAL REVIEW OF MEDICINE, VOL 72, 2021
(2021)
Article
Oncology
Axel Muendlein, Kathrin Geiger, Christine Heinzle, Stella Gaenger, Thomas Winder, Luciano Severgnini, Patrick Reimann, Eva Maria Brandtner, Andreas Leiherer, Heinz Drexel, Thomas Decker, Christoph Nonnenbroich, Tobias Dechow
Summary: RAS mutations in liquid biopsies may change over time and affect the prognosis of metastatic colorectal cancer (mCRC) patients. A study on 81 mCRC patients found that patients with a RAS mutation detected by liquid biopsy had a higher risk of death, while patients with a disappearing RAS mutation in liquid biopsy had a prolonged survival. The concentration of circulating RAS mutation also significantly affected the outcome.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
(2023)
Article
Oncology
ZeWen Xiao, Wendy Wu, Chunlong Wu, Man Li, Fuming Sun, Lu Zheng, Gaojing Liu, Xiaoling Li, Zhiyuan Yun, Jiebing Tang, Yang Yu, Shengnan Luo, Wenji Sun, Xiaohong Feng, Qian Cheng, Xue Tao, Shuangxiu Wu, Ji Tao
Summary: This study revealed distinct 5hmC signatures in cfDNA of CRC and AD patients compared to healthy controls, potentially aiding in early-stage CRC screening and assessing adenoma malignancy. The findings imply the importance of 5hmC modifications for different pathological subtypes in colorectal diseases, suggesting the need for further large-scale follow-up studies.
MOLECULAR ONCOLOGY
(2021)
Article
Health Care Sciences & Services
Stefano Signoroni, Chiara Maura Ciniselli, Guglielmo Niccolo Piozzi, Maria Teresa Ricci, Marta Pastori, Paolo Merola, Marco Bellazzi, Tatiana Smaldone, Giuseppe Rosito, Claudia Borreani, Paolo Verderio, Giovanni Apolone, Marco Vitellaro
Summary: Patients with hereditary gastrointestinal cancer predisposition syndromes reported experiencing less fear related to COVID-19 than the healthy general population. Being enrolled in a dedicated registry can reassure patients, especially during health crises, as suggested by the study results.
QUALITY OF LIFE RESEARCH
(2022)
Article
Hematology
Vincenzo Marasco, Cristiana Carniti, Anna Guidetti, Lucia Farina, Martina Magni, Rosalba Miceli, Ludovica Calabretta, Paolo Verderio, Silva Ljevar, Fabio Serpenti, Daniele Morelli, Giovanni Apolone, Giuseppe Ippolito, Chiara Agrati, Paolo Corradini
Summary: The study evaluated the serological and T-cell responses of lymphoid malignancy patients after mRNA vaccination, finding that some patients, especially those receiving anti-CD20 antibody treatment, may not effectively develop protective antibodies. T-cell responses were detected in most patients, even in seronegative individuals, but a small percentage of cases had no cellular or humoral responses. This raises concerns about the vaccine efficacy for LM patients, highlighting the need for continued protective measures.
BRITISH JOURNAL OF HAEMATOLOGY
(2022)
Article
Oncology
Alessandro Liguori, Catherine Depretto, Chiara Maura Ciniselli, Andrea Citterio, Giulia Boffelli, Paolo Verderio, Gianfranco Paride Scaperrotta
Summary: The study compared the reproducibility of contrast-enhanced digital mammography (CEDM) and magnetic resonance imaging (MRI) with postsurgical pathologic examinations, showing substantial agreement with the reference standard in both methods. Additionally, it was found that CEDM can measure and describe tumor masses comparably to MRI, indicating its potential for surgical planning.
Article
Oncology
Laura Sala, Stefano Bonomi, Alessandra Fabbri, Chiara Maura Ciniselli, Annalisa Bardelli, Paolo Verderio, Giancarlo Pruneri, Umberto Cortinovis
Summary: This study investigated the use of the PEAK PlasmaBlade and acellular dermal matrix Veritas in implant-based breast reconstruction in the setting of radiotherapy. The results showed that this approach could lead to lower complication rates and higher levels of patient and surgeon satisfaction.
Article
Oncology
Gaia Colletti, Chiara Maura Ciniselli, Stefano Signoroni, Ivana Maria Francesca Cocco, Andrea Magarotto, Maria Teresa Ricci, Clorinda Brignola, Clara Bagatin, Laura Cattaneo, Andrea Mancini, Federica Cavalcoli, Massimo Milione, Paolo Verderio, Marco Vitellaro
Summary: Prophylactic total colectomy with ileo-rectal anastomosis is a safe and effective surgical approach for familial adenomatous polyposis patients, but careful surveillance for rectal cancer is necessary.
Review
Immunology
Chiara Maura Ciniselli, Mara Lecchi, Mariangela Figini, Cecilia C. Melani, Maria Grazia Daidone, Daniele Morelli, Emanuela Zito, Giovanni Apolone, Paolo Verderio
Summary: Despite the global public health emergency of the COVID-19 pandemic, studies show that healthcare workers in Italy exhibit a robust antibody response after receiving the second vaccine dose. In a longitudinal study, 99.81% of HCWs developed an antibody response one month after the second dose, and six months later, all HCWs still showed positivity to antibodies, although at lower levels. The literature review and institutional study both confirm a strong antibody response in HCWs even seven months after completing the cycle of vaccination doses.
Article
Oncology
Monica Niger, Federico Nichetti, Andrea Casadei-Gardini, Mario Domenico Rizzato, Chiara Pircher, Marta Bini, Andrea Franza, Margherita Rimini, Valentina Burgio, Caterina Sposetti, Lorenzo Fornaro, Ilario Giovanni Rapposelli, Francesco Enrico D'Amico, Giuseppe Aprile, Caterina Vivaldi, Giovanni Luca Frassineti, Massimo Milione, Giuseppe Leoncini, Alessandro Cappetta, Enrico Vasile, Matteo Fassan, Federica Morano, Federica Perrone, Elena Tamborini, Giancarlo Pruneri, Sara Lonardi, Vincenzo Mazzaferro, Filippo Pietrantonio, Maria Di Bartolomeo, Filippo de Braud
Summary: This study investigated the impact of IDH1/2 mutations on progression-free survival, overall response rate, and disease control rate in iCCA patients treated with platinum-based chemotherapy. The results showed that IDH1/2 mutations are not associated with increased sensitivity to platinum-based chemotherapy in iCCA patients. Furthermore, the analysis of TCGA data indicated that IDH1/2 mutated CCA did not show higher HRD compared to wild-type cases.
INTERNATIONAL JOURNAL OF CANCER
(2022)
Editorial Material
Oncology
Gaia Colletti, Chiara Maura Ciniselli, Emanuele Rausa, Stefano Signoroni, Ivana Maria Francesca Cocco, Andrea Magarotto, Maria Teresa Ricci, Clorinda Brignola, Andrea Mancini, Federica Cavalcoli, Laura Cattaneo, Massimo Milione, Paolo Verderio, Marco Vitellaro
Meeting Abstract
Oncology
E. Verzoni, K. Todoerti, L. Rivoltini, V. Huber, M. Rodolfo, L. Agnelli, A. Devecchi, A. Busico, F. Perrone, G. Centonze, L. De Cecco, M. Claps, V. Guadalupi, M. Stellato, P. Giannatempo, F. G. M. De Braud, G. Procopio, P. Sepe
ANNALS OF ONCOLOGY
(2022)
Article
Endocrinology & Metabolism
Giovanni Centonze, Patrick Maisonneuve, Natalie Prinzi, Sara Pusceddu, Luca Albarello, Eleonora Pisa, Massimo Barberis, Alessandro Vanoli, Paola Spaggiari, Paola Bossi, Laura Cattaneo, Giovanna Sabella, Enrico Solcia, Stefano La Rosa, Federica Grillo, Giovanna Tagliabue, Aldo Scarpa, Mauro Papotti, Marco Volante, Alessandro Mangogna, Alessandro Del Gobbo, Stefano Ferrero, Luigi Rolli, Elisa Roca, Luisa Bercich, Mauro Benvenuti, Luca Messerini, Frediano Inzani, Giancarlo Pruneri, Adele Busico, Federica Perrone, Elena Tamborini, Alessio Pellegrinelli, Ketevani Kankava, Alfredo Berruti, Ugo Pastorino, Nicola Fazio, Fausto Sessa, Carlo Capella, Guido Rindi, Massimo Milione
Summary: This study analyzed a large series of neuroendocrine carcinomas (NECs) to validate previously identified prognostic factors and determine if additional parameters could be isolated. The most relevant predictors for prognosis were Ki-67 index, morphology, stage, and site. However, morphology was not a significant factor when Ki-67 was greater than or equal to 55%.
NEUROENDOCRINOLOGY
(2023)
Editorial Material
Agriculture, Dairy & Animal Science
Paolo Verderio, Mara Lecchi, Chiara Maura Ciniselli, Bjorn Shishmani, Giovanni Apolone, Giacomo Manenti
Summary: The 3Rs principle, consisting of Replacement, Reduction and Refinement, aims to promote ethical and scientifically valid animal experimentation. It requires the consideration of alternative models, statistical designs, and improvements in experimental conditions. The principle was first introduced in a document by the Council Directive in 1986 and developed further in the European Parliament and Council Directive in 2010. This article emphasizes the importance of the 3Rs principle, particularly the concept of Reduction, and highlights the need for its consistent implementation among countries and research teams.
Article
Gastroenterology & Hepatology
E. Rausa, G. Colletti, C. M. Ciniselli, S. Signoroni, V. Duroni, F. Cavalcoli, A. Magarotto, M. T. Ricci, C. Brignola, D. Biasoni, P. Verderio, M. Vitellaro
Summary: This study investigated the effectiveness of superior rectal artery (SRA) preservation in reducing anastomotic leakage during total colectomy with ileorectal anastomosis (TC/IRA) in patients with familial adenomatous polyposis (FAP). The results showed that SRA preservation was associated with fewer complications, lower anastomotic leakage events, and lower overall surgical complications and pelvic sepsis rates. However, it increased operative time while reducing hospital stay.
TECHNIQUES IN COLOPROCTOLOGY
(2023)
Article
Gastroenterology & Hepatology
Emanuele Rausa, Chiara Maura Ciniselli, Stefano Signoroni, Laura Sophie Boer, Lois Oldhoff, Laura Dijk, Franka Van Luijk, Maria Teresa Ricci, Chiara Ghidoli, Valeria Duroni, Clorinda Brignola, Claudia Borreani, Sara Alfieri, Giovanni Apolone, Paolo Verderio, Marco Vitellaro
Summary: This study investigated the quality of life of colorectal adenomatous polyposis patients following prophylactic surgery and found that most patients adapt to changes in bowel functioning, but a minority may face social and sexual issues.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
(2023)
Article
Biotechnology & Applied Microbiology
Susanna Zanutto, Chiara Maura Ciniselli, Antonino Belfiore, Valentina Dall'Olio, Laura Tizzoni, Luca Varinelli, Marco Alessandro Pierotti, Luigi Battaglia, Paolo Verderio, Marcello Guaglio, Manuela Gariboldi
Summary: Although miRNA signatures were not predictive of colorectal cancer recurrence, a decrease in expression of miRNAs from the CL signature was observed 1 year after surgery, while miR-335-5p from the HgA signature was higher in AWD patients before surgery. These findings suggest the potential use of miRNAs as non-invasive biomarkers for monitoring patients at risk of relapse.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
(2022)